Hi-Tech Pharmacal Co. (NASDAQ:HITK) Investor Alert: Lawsuit to Stop Takeover for $43.50 Filed
An investor, who currently hold shares of Hi-Tech Pharmacal Co. (NASDAQ:HITK) , filed a lawsuit in effort to halt the proposed takeover of Hi-Tech Pharmacal Co. by Akorn, Inc.for $43.50 per NASDAQ:HITK share.
View full press release